Recurrent Childhood Hodgkin Lymphoma

4 clinical trials · Condition

Record	Firm	Date
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01780662)	National Cancer Institute (NCI)	2013-01-31
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT01008462)	Fred Hutchinson Cancer Center	2010-03-18
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00105001)	Fred Hutchinson Cancer Center	2004-11-01
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma (NCT00005803)	Fred Hutchinson Cancer Center	1999-09-01

Every clearance here is in the API, with alerts when new ones post.